Ignite Creation Date:
2024-05-06 @ 3:08 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04535713
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2020-08-27
Brief Title:
GALLANT Metronomic Gemcitabine Doxorubicin Docetaxel and Nivolumab for Advanced Sarcoma
Sponsor:
Sarcoma Oncology Research Center LLC
Organization:
Sarcoma Oncology Research Center LLC
Organization Data
Organization:
Sarcoma Oncology Research Center LLC
Class:
OTHER
Study ID:
SOC-2082
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sarcoma Oncology Research Center LLC
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None